Inceptor Bio: Funding, Investors & Team (Sep 2026)
Inceptor Bio specializes in creating cell therapy solutions to treat complex cancers, emphasizing innovative methods for enhancing immune cell function within tumors. They offer collaboration opportunities with research programs at universities that are exploring advanced oncology treatments. By utilizing their laboratory and manufacturing capabilities, along with their team of cell and gene therapy professionals, Inceptor Bio aims to efficiently progress therapeutics from development to clinical trials.
Inceptor Bio has raised $60.6M across 3 funding rounds on record, the most recent a Series A of $21.0M announced in Feb 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Inceptor Bio Company Profile and Key Stats
Latest funding round on record: Feb 2025.
Inceptor Bio Funding Rounds
Inceptor Bio raised $37.0M in a Series A announced in May 2022.
5 months later, a Debt Financing of $2.6M was announced in Oct 2022.
2.3 years later, a Series A of $21.0M was announced in Feb 2025.
Inceptor Bio Founders and Leadership Team
Contact details for the Inceptor Bio team: 2 of 2 have an email address on file.
Start 14-day free trial →Inceptor Bio Funding Compared to Other Biotechnology Startups
Inceptor Bio's latest round of $21.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Inceptor Bio in Biotechnology and Raleigh
Companies Similar to Inceptor Bio
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Inceptor Bio Funding FAQs
What does Inceptor Bio do?
Inceptor Bio specializes in creating cell therapy solutions to treat complex cancers, emphasizing innovative methods for enhancing immune cell function within tumors. They offer collaboration opportunities with research programs at universities that are exploring advanced oncology treatments. By utilizing their laboratory and manufacturing capabilities, along with their team of cell and gene therapy professionals, Inceptor Bio aims to efficiently progress therapeutics from development to clinical trials.
How much funding has Inceptor Bio raised?
Inceptor Bio has raised $60.6M across 3 rounds on record. The most recent is a Series A of $21.0M announced in Feb 2025.
When did Inceptor Bio last raise funding?
Inceptor Bio's most recent funding round on record is a Series A of $21.0M, announced in Feb 2025.
Who founded Inceptor Bio?
FundedIQ lists Abe Maingi (Founder) at Inceptor Bio.
Who is the CEO of Inceptor Bio?
Shailesh Maingi is listed as CEO at Inceptor Bio.
Where is Inceptor Bio headquartered?
Inceptor Bio is based in Raleigh, North Carolina, United States.
How many employees does Inceptor Bio have?
Inceptor Bio is in the 11-50 employee band.
How does Inceptor Bio's funding compare to other Biotechnology startups?
Inceptor Bio's latest round of $21.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Inceptor Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Inceptor Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.